Speaks with Australian Health Professionals
Recorded Live Wednesday 9th March 2022 and Hosted by Dan Hanson of Health Alliance Australia.
Drawing from more than 20 years expertise in high-throughput protein & antibody array, proteomics technology development, automation & biomedical applications in biomarker discovery, diagnostics & personalised medicine, Professor Cahill provides clear insight into why the science surrounding Covid-19 simply does not stack up.
Professor Dolores Cahill received her Honours degree in Molecular Genetics from Trinity College Dublin (1989) and her PhD in Immunology & Biotechnology from Dublin City University (1994). She was awarded an EU ‘Human Capital and Mobility’ Post-doctoral Fellow, Technical University, Munich, Germany (1994-1995).
Since 2005 – present, she is Professor of Translational Science at UCD School of Medicine. Prof. Cahill is internationally recognised for her biomedical research, publications and patent record is in life sciences, biotechnology and in personalised healthcare and biomarkers (PHB), proteomics, biotechnology, high content protein and antibody arrays, and their biomedical, diagnostic and clinical applications.
Prof. Cahill has been involved in Scientific and Research Strategy and Policy Development and Evaluation for over 10 years. She is a member of the EU Innovative Medicines Initiative (IMI) Science Committee (2017-2019). In 2018, she was elected by the IMI SC to be Vice Chair of the IMI Scientific Committee (2019-2020).